An intramolecular Schmidt reaction strategy for the synthesis of various derivatives of crispine A using azido-ketone as a key intermediate is described.
Background
The indolizidine skeleton is one of the most important structural subunits present in numerous biologically active molecules. [1] [2] [3] [4] The polyhydroxylated indolizidines are potent inhibitors of carbohydrate processing enzymes and hence they are considered to be lead drug molecules in the treatment of metabolic diseases such as diabetes, cancer and HIV infection. [5] [6] [7] The alkyl indolizidine alkaloids, also called gephyrotoxins, are wellknown for their ability to function as non-competitive blockers of neuromuscular transmission [2] by interacting with nAChRs. In addition, the indolizidine skeleton is also present in anticancer molecules such as lepadiformine, [8] antofine, [9] and tylophorine [9] as well as a immunosuppressive agent, FR901483. [10] The wide range of biological activities associated with the indolizidine alkaloids has elicited considerable interest in them as target molecules among synthetic organic chemists. As a result, numerous synthetic approaches have been developed for the synthesis of indolizidine alkaloids. [5] [6] [7] One of the most efficient methods for the construction of the indolizidine framework is based on the intramolecular Schmidt reaction of azides with carbonyl compounds. [11, 12] Pearson and Aube have exploited the synthetic potential of the intramolecular Schmidt reaction in the synthesis of several indolizidine alkaloids. [11] [12] [13] [14] [15] Recently, we reported a novel approach for the construction of the indolizidine skeleton using an epoxide initiated electrophilic cyclization of azide as a key step. This novel methodology has been efficiently applied in the stereo-and enantioselective synthesis of indolizidine 167B and 209D (Scheme 1). [16] [17] [18] 
Results and discussion
In 2002, a new indolizidine alkaloid known as crispine A was isolated from carduus crispus, a popular invasive plant occurring in Asia and Europe, which was found to exhibit superior antitumor activity against SKOV3, KB and HeLa human cancer lines. [19] As a result of its potent antitumor activity, various synthetic methods have been developed for the synthesis of crispine A. [20] [21] [22] [23] [24] [25] [26] [27] [28] Interestingly, Schell and Smith reported the first synthesis of crispine A, even before its isolation, using the N-chloramine rearrangement reaction as a key step. [25] In order to understand the structure activity relationship (SAR) as well as to improve the efficacy of this novel anti-cancer agent, a flexible approach for the synthesis of various derivatives of crispine A is in great demand (Scheme 2). In this communication, we report the synthesis of crispine A analogues (2-5) using an intramolecular Schmidt reaction of azidoketone 6 as a key step. The azidoketone 6 can be readily prepared from the β-ketoester 7, which in turn can be synthesized from the dimethoxybenzoic acid 8 as shown in Scheme 4.
[30] 3,4-Dimethoxybenzoic acid 8 on treatment with paraformaldehyde in the presence of conc. H 2 SO 4 followed by reduction with LAH gave the corresponding diol 9 as a white crystalline solid. Diol 9 on bromination followed by nucleophilic displacement with NaCN furnished the desired dicyano compound 10. Treatment of dicyanide 10 with thionyl chloride in methanol gave the corresponding diester 11 as a colorless liquid in good yield. Compound 11 was then readily converted to the corresponding β-ketoester 7 via Dieckmann cyclization and the resultant product was purified by recrystallization using H 2 O-EtOH solvent system (Scheme 5).
Scheme 5: Synthesis of β-ketoester 7.
Our attempts towards the alkylation of β-ketoester 7 with 1-chloro-3-iodopropane under different reaction conditions were ineffective and resulted in poor yield. In order to improve the yield of the alkylation reaction, compound 7 was protected as the corresponding ethylene ketal 12 (Scheme 6). Surprisingly, alkylation of ketal-ester 12 using NaH in dry DMF proceeded smoothly even at room temperature, however it resulted in an unusual cleavage of ethylene ketal under basic conditions, leading to hydroxyvinylether 13 in 70% yield. The formation of hydroxy vinylether 13 is evident from the spectroscopic data. The presence of a sharp singlet at δ H 5.66 (s,1H) in 1 H NMR and signals corresponding to vinyl carbons (δ c 104.28, 164.39) in 13 C NMR, as well as an absorption at 3513 cm -1 in IR spectrum, clearly indicate the presence of a vinylether and a free hydroxyl group in compound 13. Reaction of hydroxy vinylether 13 with acetic anhydride yielded readily the corresponding acetate derivative 14 which further supported the formation of hydroxy vinylether under basic conditions (Scheme 6).
Reaction of 13 with NaN 3 gave the corresponding azido derivative 15 which on further treatment with DOWEX ® 50WX8H + in methanol under reflux conditions afforded the corresponding azido-ketone 6 in 81% yield (Scheme 7). Finally, the intramolecular Schmidt reaction of azidoketone 6 was successfully achieved using TfOH at -5 to 0°C and the resultant cyclized product, indolizidine derivative 3, was isolated in 54% yield (Scheme 8). Similarly, the indolizidine derivative 3a was prepared from the dicyanide 10. The structure of indolizidine derivative 3 was established by 1D and 2D NMR analyses which was unambiguously further confirmed by single crystal X-ray analysis ( Figure  1 ), on the corresponding acid derivative 4 (Scheme 9). After achieving the construction of the indolizidine skeleton using the intramolecular Schmidt reaction, our next objective was to prepare various derivatives of the anticancer agent, crispine A, starting from the key intermediate 3. Consequently, the ester functional group of the indolizidine derivative 3 was reduced with LAH in dry THF at 0°C to give the corresponding hydroxymethyl derivative 5. Mesylation of 5 with mesylchloride and triethylamine yielded the corresponding lactam 16 which on further exposure to LAH in the presence of conc. H 2 SO 4 [20] gave the methyl analogue of crispine A (2) in 80% yield (Scheme 10). Spectral data of compound 2 were found to be in complete agreement with the reported values. [26] 
Conclusion
In conclusion, we have successfully achieved the synthesis of various derivatives of crispine A (2-5), starting from the azido ketone 6, using the intramolecular Schmidt reaction as a key step. The structure of the cyclized indolizidine derivative 3 was unambiguously confirmed by single crystal X-ray analysis. Interestingly, an unusual cleavage of ethylene ketal to vinylether was observed during the alkylation of ketal-ester 12. Since the compounds 5 and 16 are highly functionalized intermediates, they can be further exploited in the synthesis of a library of anti-cancer analogues. The structure activity relationships (SAR) and anti-cancer activities of our synthetic derivatives will be reported in due course of time.
Additional material
Synthetic details, spectral properties and HRMS data.

